GlassScriptPhysician profile
Hannah E Sherrod
NPI 1801400031
$5,871.23
in general payments reported to CMS, 2019-2025
42 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,081 · 2022: $1,098 · 2023: $1,279 · 2024: $1,325 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,692.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $565.44 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $536.97 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $434.85 | 2022-2025 | Jelmyto |
| Astellas Pharma US INC | $417.76 | 2021-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $393.96 | 2022-2025 | Provenge |
| Endo Pharmaceuticals INC. | $335.30 | 2021-2024 | Xiaflex, Aveed, Edex |
| Teleflex LLC | $291.13 | 2021-2025 | Urolift, Barrigel |
| Endo USA, INC. | $231.24 | 2024-2025 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $227.77 | 2021-2025 | Prolaris |
| Rochester Medical Corporation | $215.87 | 2021-2022 | |
| Coloplast Corp | $203.83 | 2022-2025 | Speedicath |
| Pfizer INC. | $183.11 | 2021-2024 | |
| Innovation Technologies INC | $176.87 | 2022-2024 | Irrisept |
| Janssen Biotech, INC. | $169.09 | 2022-2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $138.98 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $128.50 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $113.26 | 2021-2023 | |
| Boston Scientific Corporation | $97.66 | 2021-2023 | Rezum Generator |
| Blue Earth Diagnostics | $83.24 | 2021-2024 | |
| Abbvie INC. | $78.78 | 2024-2025 | |
| 180 Medical, INC. | $76.41 | 2021-2024 | Gentlecath |
| Immunitybio, INC. | $73.16 | 2025 | |
| Novartis Pharmaceuticals Corporation | $72.84 | 2025 | |
| Baxter Healthcare | $63.29 | 2023-2025 | Perclot, Floseal |
| Urovant Sciences INC | $62.59 | 2021-2022 | |
| Clarus Therapeutics INC. | $61.30 | 2021 | |
| Progenics Pharmaceuticals, INC. | $51.45 | 2023-2025 | Pylarify |
| Halozyme INC | $39.26 | 2023 | |
| Medtronic, INC. | $37.70 | 2022-2024 | Interstim |
| Kowa Pharmaceuticals America, INC. | $35.43 | 2022-2023 | Seglentis |
| Inspire Medical Systems, INC. | $34.39 | 2025 | Inspire |
| Davol INC. | $32.97 | 2021 | |
| Abc Home Medical Supply, INC. | $31.45 | 2022-2023 | |
| Tempus Ai, INC | $29.20 | 2024 | Xt Cdx |
| Tolmar Pharmaceuticals, INC. | $28.37 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $24.91 | 2022-2024 | Trelstar |
| Tolmar, INC. | $18.81 | 2023 | |
| Novo Nordisk INC | $16.22 | 2024 | Rivfloza |
| Pacira Pharmaceuticals Incorporated | $15.88 | 2022 | |
| Gilead Sciences, INC. | $15.30 | 2023 | Veklury |
| Hollister Incorporated | $13.99 | 2023 | Infyna Chic, Vapro, Onli |
| Amgen INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Sherrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.